IVERIC bio Inc (NASDAQ:ISEE)
| 9.39 Delayed Data As of Jul 01 |  -0.23 / -2.39%Today’s Change | 6.30 Today|||52-Week Range 19.35 | -43.84% Year-to-Date |
Latest ISEE News | Press Releases
No recent news for IVERIC bio Inc.
Today’s Trading
| Previous close | 9.62 |
| Today’s open | 9.58 |
| Day’s range | 9.16 - 9.83 |
| Volume | 100,383 |
| Average volume (3 months) | 1,865,585 |
| Market cap | $1.2B |
Data as of 3:59pm ET, 07/01/2022
Growth & Valuation
| Earnings growth (last year) | +1.36% |
| Earnings growth (this year) | -14.41% |
| Earnings growth (next 5 years) | +34.02% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 3.34 |
Competitors
| ---- | ||
| RETAReata Pharmaceutical... | +0.07 | +0.23% |
| KDNYChinook Therapeutics... | +0.03 | +0.17% |
| SNDXSyndax Pharmaceutica... | -0.17 | -0.88% |
Data as of 4:00pm ET, 07/01/2022
Financials
| Next reporting date | August 3, 2022 |
| EPS forecast (this quarter) | -$0.30 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$114.5M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Parsippany, New Jersey |
Forecasts
